Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eric R.A. Vos"'
Autor:
Maarten M. Immink, Eric R.A. Vos, Alcira V.A. Janga-Jansen, Sharda Baboe-Kalpoe, Koen Hulshof, Jeffrey van Vliet, Jeroen Kerkhof, Gerco den Hartog, Hester E. de Melker, Fiona R.M. van der Klis, Nicoline A.T. van der Maas
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss , Pp 21-27 (2021)
Objectives: Pertussis is a respiratory infectious disease caused by Bordetella pertussis. In the Caribbean Netherlands (CN), comprising the islands Bonaire, St Eustatius, and Saba, registration of cases is mandatory for disease surveillance. However,
Externí odkaz:
https://doaj.org/article/83fac229753d41a5aaab686e469e213a
Autor:
Hester E. de Melker, Guy A. M. Berbers, Marjan J.M. Bogaard, Milou Ohm, Debbie M. van Rooijen, Elisabeth A. M. Sanders, Mirjam J. Knol, Fiona R. M. van der Klis, Eric R.A. Vos
Publikováno v:
Vaccine. 40:59-66
Background Meningococcal serogroup C (MenC) vaccination was introduced for 14-month-olds in the Netherlands in 2002, alongside a mass campaign for 1–18 year-olds. Due to an outbreak of serogroup W disease, MenC vaccination was replaced for MenACWY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5663c324cf75b498290d566914f29637
https://doi.org/10.1016/j.vaccine.2021.11.045
https://doi.org/10.1016/j.vaccine.2021.11.045
Autor:
Lotus L. van den Hoogen, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra, Alienke J. Wijmenga-Monsuur, Corine H. GeurtsvanKessel, Susanne P. Stoof, Daphne Reukers, Lisa A. Wijsman, Adam Meijer, Chantal B.E.M. Reusken, Nynke Y. Rots, Fiona R.M. van der Klis, Robert S. van Binnendijk, Gerco den Hartog
Publikováno v:
Vaccine, 40(15), 2251-2257. Elsevier
Background: With COVID-19 vaccine roll-out ongoing in many countries globally, monitoring of breakthrough infections is of great importance. Antibodies persist in the blood after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957343d1359782bd6b034500f04300d4
http://hdl.handle.net/10029/625628
http://hdl.handle.net/10029/625628
Autor:
Hester E. de Melker, Michiel van Boven, Fiona R. M. van der Klis, Liesbeth Mollema, Gerco den Hartog, Rob van Binnendijk, Jantien A. Backer, Eric R.A. Vos, Don Klinkenberg, Hendriek Boshuizen, Cheyenne C E van Hagen
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
This large, nationwide, population-based, seroepidemiological study provides evidence of the effectiveness of physical distancing (>1.5 m) and indoor group size reductions in reducing severe acute respiratory syndrome coronavirus 2 infection. Additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d60ce1d8f93705b67b9d174f4202ede
http://hdl.handle.net/10029/625492
http://hdl.handle.net/10029/625492
Autor:
Jeffrey van Vliet, Debbie M. van Rooijen, Denise Wong, Marjan Bogaard-van Maurik, Hester E. de Melker, Ilse Zutt, Michiel van Boven, Cheyenne C E van Hagen, Lotus L. van den Hoogen, Marije K Verheul, Fiona R. M. van der Klis, Robert S. van Binnendijk, Marjan Kuijer, Alienke J. Wijmenga-Monsuur, Eric R.A. Vos, Gerco den Hartog, Gaby Smit
mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f16283f15cdda45c6950a20580b38fd3
https://doi.org/10.1101/2021.10.25.21265467
https://doi.org/10.1101/2021.10.25.21265467
Autor:
Corine H. Geurts van Kessel, Nynke Y. Rots, Marjan Kuijer, Jeffrey van Vliet, Robert S. van Binnendijk, Eric R.A. Vos, Fiona R. M. van der Klis, Denise Wong, Hester E. de Melker, Lotus L. van den Hoogen, Alienke J. Wijmenga-Monsuur, Susanne P. Stoof, Adam Meijer, Lisa Wijsman, Daphne F.M. Reukers, Gerco den Hartog, Michiel van Boven, Chantal Reusken, Gaby Smits, Linde Woudstra, Cheyenne C E van Hagen
BackgroundWith COVID-19 vaccine roll-out ongoing in many countries globally, monitoring of breakthrough infections is of great importance. Antibodies persist in the blood after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15343968584f89f4a72cf340d3389fd
https://doi.org/10.1101/2021.10.05.21264555
https://doi.org/10.1101/2021.10.05.21264555
Autor:
Eric R.A. Vos, Alcira V.A. Janga-Jansen, Jeffrey van Vliet, Gerco den Hartog, Hester E. de Melker, Fiona R. M. van der Klis, Maarten M. Immink, Koen Hulshof, Nicoline A.T. van der Maas, Sharda Baboe-Kalpoe, Jeroen Kerkhof
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss, Pp 21-27 (2021)
Objectives Pertussis is a respiratory infectious disease caused by Bordetella pertussis. In the Caribbean Netherlands (CN), comprising the islands Bonaire, St Eustatius, and Saba, registration of cases is mandatory for disease surveillance. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e672fd9c2e5e2f017ec83174b855ea4
http://hdl.handle.net/10029/625221
http://hdl.handle.net/10029/625221
Autor:
Jacco Wallinga, Rob van Binnendijk, Fuminari Miura, Scott A. McDonald, Gerco den Hartog, Hester E. de Melker, Eric R.A. Vos, Fiona R. M. van der Klis, Michiel van Boven
BackgroundThe proportion of SARS-CoV-2 positive persons who are asymptomatic – and whether this proportion is age-dependent – are still open research questions. Because an unknown proportion of reported symptoms among SARS-CoV-2 positives will be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2d94f57f0ae0b77f57de66b112dbbeb
https://doi.org/10.1101/2021.03.29.21254334
https://doi.org/10.1101/2021.03.29.21254334
Autor:
Michiel van Boven, Jantien A. Backer, Fiona R. M. van der Klis, Eric R.A. Vos, Don Klinkenberg, Liesbeth Mollema, Hester E. de Melker, Gerco den Hartog, Rob van Binnendijk, Cheyenne C E van Hagen, Hendriek Boshuizen
This large nationwide population-based seroepidemiological study provides evidence on the effectiveness of physical distancing (>1.5m) and indoor group size reductions on SARS-CoV-2 infection. Additionally, young adults seem to play a significant rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7eee6d94aaf113712c042a586f314ca
https://doi.org/10.1101/2021.02.10.21251477
https://doi.org/10.1101/2021.02.10.21251477
Autor:
Cheyenne C E van Hagen, Michiel van Boven, Lotus L. van den Hoogen, Gerco den Hartog, Jeffrey van Vliet, Robert S. van Binnendijk, Alienke J. Wijmenga-Monsuur, Eric R.A. Vos, Elisabeth A. M. Sanders, Linde Woudstra, Fiona R. M. van der Klis, Hester E. de Melker, Gaby Smits, Rutger M. Schepp
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Assessing the duration of immunity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a first priority to gauge the degree of protection following infection. Such knowledge is lacking, especially in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ecffd39c61d0c47e7220bc3fec2c6e7
https://pubmed.ncbi.nlm.nih.gov/33730754
https://pubmed.ncbi.nlm.nih.gov/33730754